Rohto Pharmaceutical Company (PK) (RPHCF)
USOTC
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 154.6B | 171.74B | 183.58B | 188.33B | 181.29B | 199.65B | 238.66B | 270.84B |
| Operating Income | 14.72B | 18.31B | 18.41B | 21.05B | 21.96B | 28.6B | 34.04B | 39.44B |
| Pre Tax Income | 14.75B | 16.82B | 16.3B | 21.73B | 23.01B | 27.95B | 34.29B | 41.52B |
| Net Income | 10.01B | 9.29B | 9.8B | 15.41B | 16.74B | 21.02B | 26.38B | 30.94B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 84.885 | 78.763 | 83.049 | 130.495 | 141.783 | 177.984 | 111.683 | 130.986 |
| EBIT | 12.96B | 17.05B | 16.88B | 20.03B | 20.3B | 27.56B | 34.82B | 40.53B |
| EBITDA | 21.18B | 24.22B | 24.81B | 29.04B | 30.31B | 37.17B | 42.8B | 48.24B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
